クリプトフィシンP450エポキシダースの分析は,基板耐性および協同性を明らかにします
Yousong Ding1, Wolfgang H Seufert, Zachary Q Beck
1Life Sciences Institute and Department of Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan 48109, USA.
Journal of the American Chemical Society
|March 28, 2008
まとめ
P450エポキシダースCrpEは,強力な抗癌クリプトフィシンを生成する重要なステップを触媒化する. この研究は,CrpEを特徴づけている.
科学分野:
- バイオケミストリー バイオケミストリー
- 自然製品 化学 化学
- 酵素学 酵素学とは
背景:
- クリプトフィシン (Cryptophycins) は,ノストックサイアノバクテリアから派生した強力な抗がん剤です.
- C2'-C3'の位置にあるβ-エポキシドは,クリプトフィシンの抗癌作用に不可欠である.
- P450エポキシダース (CrpE) は,この重要な機能群の設置を担当しています.
研究 の 目的:
- CrpEエポキシダースの基板特異性と触媒効率を特徴付けるために.
- 活性型クリプトフィシン類の生物合成における酵素の役割を調査する.
主な方法:
- マルトース結合タンパク質 (MBP) -CrpE融合タンパク質の発現と浄化.
- 基板耐性をテストするために,クリプトフィシンアナログの化学酵素合成.
- 酵素動力学 (kcat/Km) と結合分析.
主要な成果:
- CrpEは,周期性クリプトフィシンアナログのC2'-C3'位置にベータエポキシドを特定して設置します.
- 動的パラメータ (kcat/Km) を決定し,基板構造による酵素効率の変動を明らかにした.
- 拘束分析は,MBP-CrpEが自然および非自然なデセポキシクリプトフィシン基板との協力性を示した.
結論:
- CrpEエポキシダゼは,クリプトフィシン生物合成の重要な酵素であり,高い地域およびステレオ特異性を示しています.
- CrpEの基板耐性を理解することは,新しい抗がん剤の開発を導くことができます.
- 特徴づけられたP450エポキシダゼは,天然産物合成におけるエポキシド形成の触媒機構の洞察を提供します.
関連する概念動画
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
02:24Acid-Catalyzed Ring-Opening of Epoxides
Epoxides that are three-membered ring systems are more reactive than other cyclic and acyclic ethers. The high reactivity of epoxides originates from the strain present in the ring. This ring strain acts as a driving force for epoxides to undergo ring-opening reactions either with halogen acids or weak nucleophiles in the presence of mild acid. The acid catalyst converts the epoxide oxygen, a poor leaving group, into an oxonium ion, a better leaving group, making the reaction feasible. The...
02:26Base-Catalyzed Ring-Opening of Epoxides
Due to their highly strained structures, epoxides can readily undergo ring-opening reactions through nucleophilic substitution, either in the presence of an acid or a base. The nucleophilic substitution reactions in the presence of acid are called acid-catalyzed ring-opening reactions, and nucleophilic substitution reactions in the presence of a base are called base-catalyzed ring-opening reactions. Epoxides undergo base-catalyzed ring-opening reactions in the presence of a strong nucleophile...
03:00Preparation of Epoxides
Overview
Epoxides result from alkene oxidation, which can be achieved by a) air, b) peroxy acids, c) hypochlorous acids, and d) halohydrin cyclization.
Epoxidation with Peroxy Acids
Epoxidation of alkenes via oxidation with peroxy acids involves the conversion of a carbon–carbon double bond to an epoxide using the oxidizing agent meta-chloroperoxybenzoic acid, commonly known as MCPBA. Since the O–O bond of peroxy acids is very weak, the addition of electrophilic oxygen of peroxy acids to...
Epoxides result from alkene oxidation, which can be achieved by a) air, b) peroxy acids, c) hypochlorous acids, and d) halohydrin cyclization.
Epoxidation with Peroxy Acids
Epoxidation of alkenes via oxidation with peroxy acids involves the conversion of a carbon–carbon double bond to an epoxide using the oxidizing agent meta-chloroperoxybenzoic acid, commonly known as MCPBA. Since the O–O bond of peroxy acids is very weak, the addition of electrophilic oxygen of peroxy acids to...
02:57Sharpless Epoxidation
The conversion of allylic alcohols into epoxides using the chiral catalyst was discovered by K. Barry Sharpless and is known as Sharpless epoxidation. The use of a chiral catalyst enables the formation of one enantiomer of the product in excess. This chiral catalyst is mainly a chiral complex of titanium tetraisopropoxide and tartrate ester (specific stereoisomer). The stereoisomer used in the chiral catalyst dictates the formation of the enantiomer of the product. In other words, the use of...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...